Ian Clements, Chief Financial Officer at Mirum Pharmaceuticals, Inc. (MIRM), sold 1,574 shares at $19.26 ($30K) on 2021-10-01, disclosed to the SEC on 2021-10-01.
Open-market sale of $30k MIRM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MIRM | BUY | 2020-12-28 | $46K | — | Filing → |
| MIRM | BUY | 2019-09-10 | $46K | — | Filing → |